Kybella Research Paper

In my research I will explain everything you need to know about this newly FDA approved injectable drug Kybella. My explanation will include in detail all information needed to understand this drug, what it is used to treat, the process by which treatment occurs, and the alternative treatment used in comparison to Kybella treatments. I will also explain the risks, results, and my opinion on this form of treatment. In this research, I will give you all the information you may need to make an informed decision on if this treatment could be right for you.
The trade name Kybella is not what this drug was originally known as, up until the recent approval of the drug by the FDA it was called ATX-101 by its manufacturer Kythera Biopharmaceuticals (Global Data Point, 2015). The generic name for Kybella is deoxycholic acid. Kybella is in the therapeutic class known as a cytolytic agent; which is the process of dissolution or destroying a cell. In treatment Kybella does just that by dissolving the
These reactions included swelling, bruising, pain, numbness, and formations of small areas of firmness around the treatment area (States News Service, 2015). More severe and less common reactions could be oropharyngeal pain, mandibular nerve damage (resulting in facial asymmetry), and difficulty or painful swallowing. The percentages of adverse reactions reported were as follows: mild at 81%, moderate at 17.4%, and severe at 1.6% (Journal of Drugs in Dermatology, 2015). The percentage of severe adverse reactions seems small and I feel that if the procedure is done by a trained professional it can be completed with success and safety. The most severe of reactions are only a possibility if improper technique involving injection into incorrect locations results in the medication entering skin, nerve, or muscle. With the proper injection placement these adverse reactions are easily